Patent 10485970 was granted and assigned to Medtronic on November, 2019 by the United States Patent and Trademark Office.
Prophylactic stimulation and abortive electrical stimulation are delivered to a cranial nerve, including, e.g. an occipital or trigeminal nerve to treat symptoms of various conditions, including, e.g. occipital neuralgia or migraines.